|
|
Bimatoprost
Product Name: BimatoprostSynonyms: N-Ethyl-9Alpha,11Alpha,15S-Trihydroxy-17-Phenyl-18,19,20-Trinor-Prosta-5Z, 13E-Dien-1-Amide; LUMIGAN; Bimatoprost(TM); 17-phenyl TRINOR prostaglandin F2ALPHA ethyl amideCAS: 155206-00-1MF: C25H37NO4MW: 415.5656Assay: 99%Appearance: White powderDensity 1.145g/cm3Boiling point 629.8°C at 760 mmHgRefractive index 1.591Flash point 334.7°CVapour Pressur 9.94E-17mmHg at 25°C2. Descriptions:Bimatoprost (marketed in the U.S., Canada and Europe by Allergan, under the trade name Lumigan) is a prostaglandin analog/prodrug used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. It reduces intraocular pressure (IOP) by increasing the outflow of aqueous fluid from the eyes. In December 2008, the indication to lengthen eyelashes was approved by the U.S. Food and Drug Administration (FDA); the cosmetic formulation of bimatoprost is sold as Latisse. In 2008-2011, at least three case series suggested that bimatoprost has the ability to reduce adipose (fat) tissue.
 Add to Basket
 Web address
|
help
Add to favorite
Favorite products
